MAP Pharmaceuticals, Inc. 4
4 · MAP Pharmaceuticals, Inc. · Filed May 13, 2010
Insider Transaction Report
Form 4
PERSEUS SOROS PARTNERS LLC
10% Owner
Transactions
- Other
Common Stock
2010-05-11−1,000,000→ 1,826,169 total(indirect: See Footnotes)
Footnotes (2)
- [F1]The securities reported herein are held for the account of Perseus-Soros BioPharmaceutical Fund, LP ("Perseus-Soros"). Perseus-Soros Partners, LLC is the general partner of Perseus-Soros.
- [F2]On May 11, 2010, Perseus-Soros distributed 1,000,000 shares of the Issuers Common Stock pro rata to its partners for no consideration and certain partners of Perseus-Soros have made subsequent pro rata distributions to their respective partners or members for no consideration (collectively, the "Distributions").